Susquehanna International Group
NAUT icon

Susquehanna International Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Susquehanna International Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-93,500
Closed -$259K – 12763
2023
Q1 		$259K Buy
+93,500
New +$196K ﹤0.01% 10044
2022
Q2 		– Sell
-16,000
Closed -$69K – 13579
2022
Q1 		$69K Sell
16,000
-17,400
-52% -$71.4K ﹤0.01% 12140
2021
Q4 		$173K Buy
33,400
+3,300
+11% +$17.7K ﹤0.01% 11624
2021
Q3 		$185K Buy
30,100
+5,400
+22% +$43K ﹤0.01% 11579
2021
Q2 		$249K Buy
+24,700
New +$268K ﹤0.01% 11150

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group's NAUT Position: Q1 2026 in Review

Susquehanna International Group sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 42,916 shares — an estimated $105K sold.

Susquehanna International Group first reported a position in NAUT in Q2 2021 and held it in 14 quarters. The position peaked at $1.31M in Q3 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Susquehanna International Group reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 42,916 Nautilus Biotechnolgy shares in Q1 2026, an estimated $105K.
  • Susquehanna International Group first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 14 quarters.
  • Susquehanna International Group's Nautilus Biotechnolgy position peaked at $1.31M in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.